Inventor
CROCI TIZIANO
IT25 patents
⚠️ This page may combine multiple inventors who share the name “CROCI TIZIANO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANOFI SA
15 patentsUS5488151AJan 30, 1996
{(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino)-2-hydroxyethylamino]5,} acetic acid and its pharmaceutically acceptable salts
SANOFI SA21 citations92
US4707497ANov 17, 1987
Phenylethanolaminotetralines, a process for their preparation and pharmaceutical compositions containing them
SANOFI SA29 citations92
US5281606AJan 25, 1994
N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
SANOFI SA24 citations91
US5502063AMar 26, 1996
1-halopyridin-4-amino-4-alkylpiperidines
SANOFI SA5 citations73
US5109005AApr 28, 1992
Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
SANOFI SA11 citations73
US5002946AMar 26, 1991
Phenylethanolamine analog active compounds for the treatment of gastrointestinal diseases
SANOFI SA12 citations73
US5618822AApr 8, 1997
N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
SANOFI SA9 citations72
US5559238ASep 24, 1996
N-substituted trifluoromethylphenyltetrahydropyridenes process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
SANOFI SA6 citations72
US5462945AOct 31, 1995
N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
SANOFI SA4 citations72
US5955474ASep 21, 1999
Use of neurotensin antagonists for the treatment of edematous conditions
SANOFI SA1 citations52
US5723611AMar 3, 1998
Heteroarylpiperidines
SANOFI SA0 citations51
US5595994AJan 21, 1997
1-Halopyrazin- and 1-halopyrimidin-4-amino-4-alkylpiperidines
SANOFI SA0 citations51
US5596101AJan 21, 1997
N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
SANOFI SA0 citations51
US9763940B2Sep 19, 2017
Therapeutic use of P75 receptor antagonists
SANOFI SA0 citations45
US5599941AFeb 4, 1997
N-substituted trifluoromethylphenyltetrahydropyridines process for the preparation thereof intermediates in said process and pharmaceutical compositions containing them
SANOFI SA0 citations45
SANOFI AVENTIS
6 patentsUS7453010B2Nov 18, 2008
Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
SANOFI AVENTIS19 citations83
US7718646B2May 18, 2010
Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
SANOFI AVENTIS0 citations51
US7419974B2Sep 2, 2008
Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
SANOFI AVENTIS0 citations51
US7388031B2Jun 17, 2008
Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
SANOFI AVENTIS0 citations51
US7030160B2Apr 18, 2006
Propanolaminotetralines, preparation thereof and compositions containing same
SANOFI AVENTIS1 citations50
US7625929B2Dec 1, 2009
Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
SANOFI AVENTIS0 citations41
SANOFI ELF
3 patentsUS5266573ANov 30, 1993
Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
SANOFI ELF47 citations92
US5604245AFeb 18, 1997
Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment of conditions deriving from disorders of the serotoninergic systems mediated by 5-HT3 receptors
SANOFI ELF10 citations72
US5270341ADec 14, 1993
Method of treatment or prophylaxis of depression and stress
SANOFI ELF6 citations69